277 related articles for article (PubMed ID: 36835983)
1. Pediatric Diabetic Nephropathy: Novel Insights from microRNAs.
Lanzaro F; Barlabà A; De Nigris A; Di Domenico F; Verde V; Miraglia Del Giudice E; Di Sessa A
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835983
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.
Kato M; Natarajan R
Ann N Y Acad Sci; 2015 Sep; 1353(1):72-88. PubMed ID: 25877817
[TBL] [Abstract][Full Text] [Related]
3. Review of early circulating biomolecules associated with diabetes nephropathy - Ideal candidates for early biomarker array test for DN.
Quan KY; Yap CG; Jahan NK; Pillai N
Diabetes Res Clin Pract; 2021 Dec; 182():109122. PubMed ID: 34742785
[TBL] [Abstract][Full Text] [Related]
4. The role of microRNAs in diabetic nephropathy.
Wu H; Kong L; Zhou S; Cui W; Xu F; Luo M; Li X; Tan Y; Miao L
J Diabetes Res; 2014; 2014():920134. PubMed ID: 25258717
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
Dewanjee S; Bhattacharjee N
Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170
[TBL] [Abstract][Full Text] [Related]
6. Interactions Among Non-Coding RNAs in Diabetic Nephropathy.
Loganathan TS; Sulaiman SA; Abdul Murad NA; Shah SA; Abdul Gafor AH; Jamal R; Abdullah N
Front Pharmacol; 2020; 11():191. PubMed ID: 32194418
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.
Simpson K; Wonnacott A; Fraser DJ; Bowen T
Curr Diab Rep; 2016 Mar; 16(3):35. PubMed ID: 26973290
[TBL] [Abstract][Full Text] [Related]
8. The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy.
Tang J; Yao D; Yan H; Chen X; Wang L; Zhan H
Int J Endocrinol; 2019; 2019():8719060. PubMed ID: 31885563
[TBL] [Abstract][Full Text] [Related]
9. Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.
Campion CG; Sanchez-Ferras O; Batchu SN
Can J Kidney Health Dis; 2017; 4():2054358117705371. PubMed ID: 28616250
[TBL] [Abstract][Full Text] [Related]
10. Eight Differential miRNAs in DN Identified by Microarray Analysis as Novel Biomarkers.
Tu C; Wei L; Wang L; Tang Y
Diabetes Metab Syndr Obes; 2022; 15():907-920. PubMed ID: 35359345
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.
Zhou H; Ni WJ; Meng XM; Tang LQ
Front Cell Dev Biol; 2020; 8():618536. PubMed ID: 33569382
[TBL] [Abstract][Full Text] [Related]
12. Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy.
Mafi A; Yadegar N; Salami M; Salami R; Vakili O; Aghadavod E
Pathol Res Pract; 2021 Nov; 227():153618. PubMed ID: 34649056
[TBL] [Abstract][Full Text] [Related]
13. Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy.
Ming J; Sana SRGL; Deng X
Front Endocrinol (Lausanne); 2022; 13():978601. PubMed ID: 36329882
[TBL] [Abstract][Full Text] [Related]
14. Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy.
Conserva F; Barozzino M; Pesce F; Divella C; Oranger A; Papale M; Sallustio F; Simone S; Laviola L; Giorgino F; Gallone A; Pontrelli P; Gesualdo L
Sci Rep; 2019 Aug; 9(1):11357. PubMed ID: 31388051
[TBL] [Abstract][Full Text] [Related]
15. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.
Yang Y; Xiao L; Li J; Kanwar YS; Liu F; Sun L
Med Hypotheses; 2013 Aug; 81(2):274-8. PubMed ID: 23683774
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes.
Ghai V; Wu X; Bheda-Malge A; Argyropoulos CP; Bernardo JF; Orchard T; Galas D; Wang K
Kidney Int Rep; 2018 May; 3(3):555-572. PubMed ID: 29854963
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.
Rubin A; Salzberg AC; Imamura Y; Grivitishvilli A; Tombran-Tink J
BMC Genomics; 2016 Nov; 17(1):936. PubMed ID: 27855634
[TBL] [Abstract][Full Text] [Related]
18. RNA expression signatures and posttranscriptional regulation in diabetic nephropathy.
Rudnicki M; Beckers A; Neuwirt H; Vandesompele J
Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv35-42. PubMed ID: 26209736
[TBL] [Abstract][Full Text] [Related]
19. Emerging Roles of microRNAs as Biomarkers and Therapeutic Targets for Diabetic Neuropathy.
Fan B; Chopp M; Zhang ZG; Liu XS
Front Neurol; 2020; 11():558758. PubMed ID: 33192992
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs and Risk Factors for Diabetic Nephropathy in Egyptian Children and Adolescents with Type 1 Diabetes.
Abdelghaffar S; Shora H; Abdelatty S; Elmougy F; El Sayed R; Abdelrahman H; Soliman H; Algebaly H; Ahmed S; Alfy P; Elshiwy Y
Diabetes Metab Syndr Obes; 2020; 13():2485-2494. PubMed ID: 32765027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
